These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 2146961)
1. Effects of monovalent cations on neostriatal dopamine D2 receptors labeled with [3H]raclopride. Reader TA; Boulianne S; Molina-Holgado E; Dewar KM Biochem Pharmacol; 1990 Oct; 40(8):1739-46. PubMed ID: 2146961 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of modulation of [3H]raclopride binding to dopaminergic receptors in rat striatal membranes by sodium ions. Lepiku M; Järv J; Rinken A; Fuxe K Neurochem Int; 1997 Jun; 30(6):575-81. PubMed ID: 9152999 [TBL] [Abstract][Full Text] [Related]
3. Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity. Dewar KM; Montreuil B; Grondin L; Reader TA J Pharmacol Exp Ther; 1989 Aug; 250(2):696-706. PubMed ID: 2527300 [TBL] [Abstract][Full Text] [Related]
4. Specific [3H]raclopride binding to neostriatal dopamine D2 receptors: role of disulfide and sulfhydryl groups. Reader TA; Molina-Holgado E; Lima L; Boulianne S; Dewar KM Neurochem Res; 1992 Aug; 17(8):749-59. PubMed ID: 1379349 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand. Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586 [TBL] [Abstract][Full Text] [Related]
6. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression. Sumiyoshi T; Stockmeier CA; Overholser JC; Thompson PA; Meltzer HY Brain Res; 1995 May; 681(1-2):109-16. PubMed ID: 7552267 [TBL] [Abstract][Full Text] [Related]
7. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519 [TBL] [Abstract][Full Text] [Related]
8. Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors. Reader TA; Molina-Holgado E; Dewar KM Mol Neurobiol; 1992; 6(4):425-50. PubMed ID: 1285933 [TBL] [Abstract][Full Text] [Related]
9. Effects of chronic lithium treatments on central dopaminergic receptor systems: G proteins as possible targets. Carli M; Anand-Srivastava MB; Molina-Holgado E; Dewar KM; Reader TA Neurochem Int; 1994 Jan; 24(1):13-22. PubMed ID: 8130731 [TBL] [Abstract][Full Text] [Related]
10. Characterization of [3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides. Malmberg A; Mohell N J Pharmacol Exp Ther; 1995 Aug; 274(2):790-7. PubMed ID: 7636742 [TBL] [Abstract][Full Text] [Related]
11. Dopamine D1 receptors are involved in the modulation of D2 receptors induced by cholecystokinin receptor subtypes in rat neostriatal membranes. Li XM; Hedlund PB; Agnati LF; Fuxe K Brain Res; 1994 Jul; 650(2):289-98. PubMed ID: 7953694 [TBL] [Abstract][Full Text] [Related]
12. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes. Hamblin MW; Leff SE; Creese I Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712 [TBL] [Abstract][Full Text] [Related]
13. Effects of mono- and divalent ions on the binding of the adenosine analogue CGS 21680 to adenosine A2 receptors in rat striatum. Johansson B; Parkinson FE; Fredholm BB Biochem Pharmacol; 1992 Dec; 44(12):2365-70. PubMed ID: 1472101 [TBL] [Abstract][Full Text] [Related]
14. Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide. Grigoriadis D; Seeman P J Neurochem; 1985 Jun; 44(6):1925-35. PubMed ID: 3157782 [TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride. Lidow MS; Goldman-Rakic PS; Rakic P; Innis RB Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6412-6. PubMed ID: 2548214 [TBL] [Abstract][Full Text] [Related]
16. Effects of sodium, lithium, and magnesium on in vitro binding of [3H]SCH23390 in rat neostriatum and cerebral cortex. Gottberg E; Diop L; Montreuil B; Reader TA Neurochem Res; 1989 May; 14(5):419-26. PubMed ID: 2526301 [TBL] [Abstract][Full Text] [Related]
18. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum. Terai M; Hidaka K; Nakamura Y Eur J Pharmacol; 1989 Dec; 173(2-3):177-82. PubMed ID: 2576228 [TBL] [Abstract][Full Text] [Related]
19. Effects of monovalent and divalent cations and of guanine nucleotides on binding of vasopressin to the rat mesenteric vasculature. Larivière R; Schiffrin EL Can J Physiol Pharmacol; 1987 Jun; 65(6):1171-81. PubMed ID: 2957041 [TBL] [Abstract][Full Text] [Related]
20. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum. Hall H; Wedel I Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):368-73. PubMed ID: 2943136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]